|
[1]
|
朱云龙, 高圳昱, 黄侠, 等. 系统性硬化症相关间质性肺疾病的治疗进展[J]. 湖北民族大学学报(医学版), 2025, 42(2): 76-80+84.
|
|
[2]
|
王珂, 胡子涛, 崔露露, 等. 基于定量CT评估CTD-ILD肺纤维化严重程度的研究[J]. CT理论与应用研究(中英文), 2025, 34(4): 589-597.
|
|
[3]
|
赵静, 王静, 王勇, 等, 成人多发性肌炎/皮肌炎患者合并间质性肺疾病的危险因素分析[J]. 内蒙古医科大学学报, 2025, 47(3): 274-279.
|
|
[4]
|
郭丹丹, 李林, 贾霜, 等. 类风湿性关节炎相关肺间质病变的HRCT表现及危险因素研究[J]. 川北医学院学报, 2024, 39(4): 452-456.
|
|
[5]
|
史小芳, 俞敏, 陈永华, 等. 结缔组织病合并间质性肺疾病患者血清中甲壳质酶蛋白40和涎液化糖链抗原的水平变化及临床意义[J]. 中国现代医药杂志, 2025, 27(8): 66-70.
|
|
[6]
|
Oldham, J.M., Adegunsoye, A., Valenzi, E., Lee, C., Witt, L., Chen, L., et al. (2016) Characterisation of Patients with Interstitial Pneumonia with Autoimmune Features. European Respiratory Journal, 47, 1767-1775. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
王太珊. 45例具有自身免疫特征的间质性肺炎患者的临床特征分析[D]: [硕士学位论文]. 遵义: 遵义医科大学, 2024.
|
|
[8]
|
Solomon, J.J., Matson, S., Kelmenson, L.B., Chung, J.H., Hobbs, S.B., Rosas, I.O., et al. (2020) IgA Antibodies Directed against Citrullinated Protein Antigens Are Elevated in Patients with Idiopathic Pulmonary Fibrosis. Chest, 157, 1513-1521. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Rzepka-Wrona, P., Skoczyński, S. and Barczyk, A. (2022) Are There Differences in Inflammatory and Fibrotic Pathways between IPAF, CTD-ILDs, and IIPs? A Single-Center Pilot Study. International Journal of Molecular Sciences, 23, Article No. 15205. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Vivero, F., Campins, F., Lancellotti, D., Malfante, P., Babini, S., Sebastiani, J., et al. (2019) Autoimmune Interstitial Lung Disease in Latin-America. Clinical Immunology, 199, 52-56. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Joerns, E.K., Adams, T.N., Newton, C.A., Bermas, B., Karp, D., Batra, K., et al. (2022) Variables Associated with Response to Therapy in Patients with Interstitial Pneumonia with Autoimmune Features. JCR: Journal of Clinical Rheumatology, 28, 84-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Karampeli, M., Thomas, K., Flouda, S., Chavatza, A., Nikolopoulos, D., Pieta, A., et al. (2020) Interstitial Pneumonia with Autoimmune Features (IPAF): A Single-Centre, Prospective Study. Mediterranean Journal of Rheumatology, 31, 330-336. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Alevizos, M.K., Giles, J.T., Patel, N.M. and Bernstein, E.J. (2019) Risk of Progression of Interstitial Pneumonia with Autoimmune Features to a Systemic Autoimmune Rheumatic Disease. Rheumatology, 59, 1233-1240. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
张靖, 赵琳, 曹凤华, 等. 间质性肺炎高分辨率CT的影像学特征分析[J]. 医学影像学杂志, 2025, 35(2): 148-150+162.
|
|
[15]
|
Chartrand, S., Swigris, J.J., Stanchev, L., Lee, J.S., Brown, K.K. and Fischer, A. (2016) Clinical Features and Natural History of Interstitial Pneumonia with Autoimmune Features: A Single Center Experience. Respiratory Medicine, 119, 150-154. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Auteri, S., Alberti, M.L., Fernández, M.E., Blanco, G., Rayá, M., Guman, G., et al. (2021) Occult Primary Sjögren Syndrome in Patients with Interstitial Pneumonia with Autoimmune Features. Respiratory Medicine, 182, Article ID: 106405. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Mackintosh, J.A., Wells, A.U., Cottin, V., Nicholson, A.G. and Renzoni, E.A. (2021) Interstitial Pneumonia with Autoimmune Features: Challenges and Controversies. European Respiratory Review, 30, Article ID: 210177. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Liang, L., Zhang, Y., Shen, Y., Song, A., Li, W., Ye, L., et al. (2021) Aberrantly Expressed Galectin-9 Is Involved in the Immunopathogenesis of Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease. Frontiers in Cell and Developmental Biology, 9, Article ID: 628128. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
张子旖. 探究具有自身免疫特征的间质性肺炎肺内和全身炎症因子谱及其对预后的影响[D]: [硕士学位论文]. 广州: 广州医科大学, 2022.
|
|
[20]
|
丁东延. MiR-221-5p负调控MUC5B基因介导EMT在肺纤维化形成中的作用及机制研究[D]: [博士学位论文]. 长春: 吉林大学, 2024.
|
|
[21]
|
Kameda, M., Otsuka, M., Chiba, H., Kuronuma, K., Hasegawa, T., Takahashi, H., et al. (2020) CXCL9, CXCL10, and CXCL11; Biomarkers of Pulmonary Inflammation Associated with Autoimmunity in Patients with Collagen Vascular Diseases-Associated Interstitial Lung Disease and Interstitial Pneumonia with Autoimmune Features. PLOS ONE, 15, e0241719. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Cho, H.K., Chung, M.P., Soo Lee, K., Chung, M.J., Han, J., Kwon, O.J., et al. (2022) Clinical Characteristics and Prognostic Factors of Fibrotic Nonspecific Interstitial Pneumonia. Therapeutic Advances in Respiratory Disease, 16. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
D’Silva, K.M., Ventura, I.B., Bolster, M.B., Castelino, F.V., Sharma, A., Little, B.P., et al. (2021) Rituximab for Interstitial Pneumonia with Autoimmune Features at Two Medical Centres. Rheumatology Advances in Practice, 5, ii1-ii9. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
李明宇, 高丽. 吡非尼酮在结缔组织病相关间质性肺疾病中的应用进展[J]. 医学研究与战创伤救治, 2023, 36(10): 1100-1104.
|
|
[25]
|
魏海霞, 宋永娜, 韩春兰. 尼达尼布治疗进展性纤维化性间质性肺疾病的临床疗效及对患者血清白细胞介素-6和中性粒细胞弹性蛋白酶水平的影响[J]. 新乡医学院学报, 2025, 42(7): 575-578.
|
|
[26]
|
Kreuter, M., Maher, T.M., Corte, T.J., Molina-Molina, M., Axmann, J., Gilberg, F., et al. (2021) Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use. Advances in Therapy, 39, 1081-1095. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
张美泉, 陈公平. IPAF合并肺部感染的影响因素及诺莫图预测模型构建[J]. 中国现代医药杂志, 2024, 26(10): 55-59.
|
|
[28]
|
Li, Y., Li, S., Zhu, J., Wang, Z. and Zhang, X. (2024) Establishment and Validation of Clinical Prediction Model and Prognosis of Perioperative Pneumonia in Elderly Patients with Hip Fracture Complicated with Preoperative Acute Heart Failure. BMC Surgery, 24, Article No. 369. [Google Scholar] [CrossRef] [PubMed]
|